Hickie I, Bennett B, Mitchell P, Wilhelm K, Orlay W
School of Psychiatry, University of New South Wales, Academic Department of Psychiatry, St George Hospital and Community Service, Kogarah, Australia.
Aust N Z J Psychiatry. 1996 Apr;30(2):246-52. doi: 10.3109/00048679609076101.
To investigate the relationship between hypothyroidism and treatment-resistant depression (TRD).
A retrospective case audit of 93 inpatients of a specialist Mood Disorders Unit. Patients referred with TRD were sub-classified into 'adequate' or 'inadequate' prior treatment groups on the basis of pre-established criteria, and compared with a 'non-TRD' control sample. Grades I (clinical) and II (subclinical) hypothyroidism were determined by review of relevant thyroid indices.
Patients had chronic depressive disorders (sub-group means of 57.5-82.2 weeks of illness). Of those patients referred with TRD, 22% (10/46) had evidence of clinical or subclinical hypothyroidism compared with 2% (1/47) of the non-TRD patients (p < 0.01). A gradient in the rates of grade I hypothyroidism was observed with the adequately-treated TRD patients having the highest rate (13%), the inadequately-treated TRD patients having an intermediate rate (7%), and the non-TRD patients having the lowest rate (2%). Consistent with this view, the inadequately-treated TRD group had the highest rate of grade II hypothyroidism (p = 0.01) and tended to have higher thyroid stimulating hormone (TSH) values (p = 0.06). Differences in the rates of hypothyroidism could not be accounted for by differences in age or prior exposure to lithium and/or carbamazepine. Duration of the depressive episode was negatively correlated with both the free thyroxine indices (r = -0.25, P < 0.05) and TSH levels (r = -0.32, p < 0.01).
This study suggests that relative hypothyroidism may play a role in the development of some treatment-resistant depressive disorders.
探讨甲状腺功能减退与难治性抑郁症(TRD)之间的关系。
对某专科情绪障碍科的93例住院患者进行回顾性病例审核。根据既定标准,将转诊的TRD患者分为“充分”或“不充分”的既往治疗组,并与“非TRD”对照样本进行比较。通过审查相关甲状腺指标来确定I级(临床)和II级(亚临床)甲状腺功能减退。
患者患有慢性抑郁症(亚组平均病程为57.5 - 82.2周)。在转诊的TRD患者中,22%(10/46)有临床或亚临床甲状腺功能减退的证据,而非TRD患者为2%(1/47)(p < 0.01)。观察到I级甲状腺功能减退发生率存在梯度变化,充分治疗的TRD患者发生率最高(13%),治疗不充分的TRD患者发生率居中(7%),非TRD患者发生率最低(2%)。与此观点一致,治疗不充分的TRD组II级甲状腺功能减退发生率最高(p = 0.01),且促甲状腺激素(TSH)值往往更高(p = 0.06)。甲状腺功能减退发生率的差异不能用年龄差异或既往使用锂盐和/或卡马西平来解释。抑郁发作持续时间与游离甲状腺素指数(r = -0.25,P < 0.05)和TSH水平(r = -0.32,p < 0.01)均呈负相关。
本研究表明,相对性甲状腺功能减退可能在某些难治性抑郁症的发生中起作用。